EuroMed isn't flying blind here. The lean, but hig

EuroMed isn't flying blind here. The lean, but highly seasoned team, which
includes Dr. David Dalton, former EVP of Rite Aid and current director of
Pennsylvania-licensed cannabis producer and processor AGRiMED, as a director,
has some good comps to base their projections upon. For instance, fellow
Israeli cannabis company InterCure is able to produce 10,000 kilograms
annually on their 54,450 square foot property.

The Israeli-benefit abounds on this front too when considering that Canadian
greenhouse cannabis cultivator Tantalus Labs is able to produce only 10,000
kilograms annually from its 120,000 square foot facility.

LAB TOO

The company also intends to have an extraction lab to cater to an extracts
market expected to be worth $130 billion globally by 2029. There are many
benefits to this type of vertical integration, including better yields by
using every part of the plant and increasing shelf life without fear of loss
of raw material. Canada is trying to iron out laws about edibles, as are other
parts of the world, making this a market segment than cannot be overlooked,
albeit for pharmaceuticals or an additive for an infused sports drink.